Metformin use in decompensated heart failure

Cardiology in Review
Alex Boyd, James Nawarskas

Abstract

Metformin is associated with decreased mortality and morbidity in stable heart failure patients with diabetes mellitus type II. Diabetic heart failure patients with elevated systolic blood pressure are at increased risk for developing acute decompensated heart failure, which is often associated with decreased kidney function. Metformin-associated lactic acidosis is a rare but fatal side effect that may occur when kidney function is decreased. During acute decompensated heart failure, timely treatment may prevent the decrease in kidney function to the threshold associated with an increased risk of metformin-associated lactic acidosis. Metformin should not be withheld in diabetic patients with stable heart failure who do not have other risk factors for acute decompensated heart failure or lactic acidosis.

References

May 1, 1990·Drugs·D J Black, R B Livingston
May 7, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J D Lalau, J M Race
Sep 7, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·A HolsteinE H Egberts
Jul 26, 2002·Journal of Cardiac Failure·Stephen S GottliebHarlan M Krumholz
Jan 13, 2004·Journal of the American College of Cardiology·Daniel E FormanHarlan M Krumholz
Jan 30, 2004·Journal of Internal Medicine·A M E StadesJ B L Hoekstra
Jan 18, 2006·The American Journal of the Medical Sciences·Chetan Shenoy
May 9, 2006·Journal of Cardiac Failure·Theophilus E OwanMargaret M Redfield
May 16, 2006·Journal of the American College of Cardiology·Grace L SmithHarlan M Krumholz
Mar 22, 2007·The Annals of Pharmacotherapy·Felicia Roberts, Gina J Ryan
Aug 4, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·J S ShawE S Kilpatrick
Nov 29, 2007·Diabetes Care·Silvio E InzucchiDarren K McGuire
Feb 15, 2008·Critical Care Medicine·Kelly V LiangMargaret M Redfield
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Dec 14, 2011·Expert Opinion on Pharmacotherapy·Nikolaos PapanasDimitri P Mikhailidis
Feb 27, 2017·Diabetes & Metabolism Journal·Manoja K BrahmaAdam R Wende
Feb 13, 2009·Expert Review of Cardiovascular Therapy·Ana C Alba, Diego H Delgado

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.